NCBI Taxonomy: 66883

Streptomyces cyaneofuscatus (ncbi_taxid: 66883)

found 18 associated metabolites at species taxonomy rank level.

Ancestor: Streptomyces griseus group

Child Taxonomies: none taxonomy data.

Valinomycin

(3S,6S,9R,12R,15S,18S,21R,24R,27S,30S,33R,36R)-6,18,30-trimethyl-3,9,12,15,21,24,27,33,36-nona(propan-2-yl)-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone

C54H90N6O18 (1110.6311)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D049990 - Membrane Transport Modulators D007476 - Ionophores A twelve-membered cyclodepsipeptide composed of three repeating D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl units joined in sequence. An antibiotic found in several Streptomyces strains. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic Valinomycin is a potassium-specific ionophore, the valinomycin-K+ complex can be incorporated into biological bilayer membranes with the hydrophobic surface of valinomycin, destroys the normal K+ gradient across the membrane, and as a result kills the cells, incorporating into liposomes can significantly reduces the cytotoxicity and enhances the targeting effect. Valinomycin exhibits antibiotic, antifungal, antiviral, antitumor and insecticidal efficacy, thus can be used for relevant research[1][2]. Valinomycin (NSC 122023), a cyclic depsipeptide antibiotic, act as a potassium selective ionophore. Valinomycin (NSC 122023) inhibits lymphocyte proliferation by its effects on the cell membrane, and induces apoptosis in CHO cells[1]. Valinomycin induces activation of PINK1 leading to Parkin Ser65 phosphorylation[2].

   

Daunorubicin

(8S,10S)-8-acetyl-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

C27H29NO10 (527.1791)


Daunorubicin is only found in individuals that have used or taken this drug. It is a very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms. [PubChem]Daunorubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Daunorubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors KEIO_ID D106

   

3-Hydroxyquinaldic acid

3-Hydroxyquinoline-2-carboxylic acid

C10H7NO3 (189.0426)


   

anthracimycin

anthracimycin

C25H32O4 (396.23)


   

3,7-Dihydroxytropolone

3,7-Dihydroxytropolone

C7H6O4 (154.0266)


A cyclic ketone that is tropolone in which the hydrogens at positions 3 and 7 are substituted by hydroxy groups. It is isolated from the soil bacterium Streptomyces tropolofaciens strain K611-97.

   

Daunorubicin

(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione

C27H29NO10 (527.1791)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent A natural product found in Actinomadura roseola. D004791 - Enzyme Inhibitors

   

(2r)-2-({hydroxy[2-(3-hydroxyquinolin-2-yl)-1,3-oxazol-4-yl]methylidene}amino)-3-sulfanylpropanoic acid

(2r)-2-({hydroxy[2-(3-hydroxyquinolin-2-yl)-1,3-oxazol-4-yl]methylidene}amino)-3-sulfanylpropanoic acid

C16H13N3O5S (359.0576)


   

(3r,6r,9s,12s,15r,18r,21s,24s,27r,30r,33s,36s)-5,11,17,23,29,35-hexahydroxy-3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriaconta-4,10,16,22,28,34-hexaene-2,8,14,20,26,32-hexone

(3r,6r,9s,12s,15r,18r,21s,24s,27r,30r,33s,36s)-5,11,17,23,29,35-hexahydroxy-3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriaconta-4,10,16,22,28,34-hexaene-2,8,14,20,26,32-hexone

C54H90N6O18 (1110.6311)


   

1,6,10-trihydroxy-2-(4-hydroxy-5-{[4-hydroxy-6-methyl-5-({6-methyl-5-[(6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]oxan-2-yl}oxy)oxan-2-yl]oxy}-6-methyloxan-2-yl)-8-methyltetracene-5,12-dione

1,6,10-trihydroxy-2-(4-hydroxy-5-{[4-hydroxy-6-methyl-5-({6-methyl-5-[(6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]oxan-2-yl}oxy)oxan-2-yl]oxy}-6-methyloxan-2-yl)-8-methyltetracene-5,12-dione

C43H48O15 (804.2993)


   

2,3,7-trihydroxycyclohepta-2,4,6-trien-1-one

2,3,7-trihydroxycyclohepta-2,4,6-trien-1-one

C7H6O4 (154.0266)


   

(3r,6r,9s,12s,15r,18r,21s,24s,30r,33s,36s)-5,11,17,23,29,35-hexahydroxy-3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriaconta-4,10,16,22,28,34-hexaene-2,8,14,20,26,32-hexone

(3r,6r,9s,12s,15r,18r,21s,24s,30r,33s,36s)-5,11,17,23,29,35-hexahydroxy-3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriaconta-4,10,16,22,28,34-hexaene-2,8,14,20,26,32-hexone

C54H90N6O18 (1110.6311)


   

3-hydroxyquinoline-2-carboxamide

3-hydroxyquinoline-2-carboxamide

C10H8N2O2 (188.0586)


   

(2s)-3-hydroxy-2-[(3-hydroxyquinolin-2-yl)formamido]propanoic acid

(2s)-3-hydroxy-2-[(3-hydroxyquinolin-2-yl)formamido]propanoic acid

C13H12N2O5 (276.0746)


   

(7r,12s,12ar,14ar,18r,18as,18bs)-3-hydroxy-7,12,16,18-tetramethyl-2h,3h,4h,7h,12h,12ah,14ah,15h,18h,18ah,18bh-naphtho[1,2-g]oxacyclotetradecane-1,5-dione

(7r,12s,12ar,14ar,18r,18as,18bs)-3-hydroxy-7,12,16,18-tetramethyl-2h,3h,4h,7h,12h,12ah,14ah,15h,18h,18ah,18bh-naphtho[1,2-g]oxacyclotetradecane-1,5-dione

C25H34O4 (398.2457)


   

(1e,3e,18z)-11-ethyl-2,20,24,27-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaene-7,28-dione

(1e,3e,18z)-11-ethyl-2,20,24,27-tetrahydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,18,20,26-pentaene-7,28-dione

C29H38N2O6 (510.273)


   

(7r,12s,12ar,14ar,18as,18br)-3-hydroxy-7,12,16-trimethyl-2h,3h,4h,7h,12h,12ah,14ah,15h,18h,18ah,18bh-naphtho[1,2-g]oxacyclotetradecane-1,5-dione

(7r,12s,12ar,14ar,18as,18br)-3-hydroxy-7,12,16-trimethyl-2h,3h,4h,7h,12h,12ah,14ah,15h,18h,18ah,18bh-naphtho[1,2-g]oxacyclotetradecane-1,5-dione

C24H32O4 (384.23)


   

3-(1-hydroxy-5-methylhexyl)-4-(hydroxymethyl)oxolan-2-one

3-(1-hydroxy-5-methylhexyl)-4-(hydroxymethyl)oxolan-2-one

C12H22O4 (230.1518)


   

(2s)-4-(c-hydroxycarbonimidoyl)-2-[(3-hydroxyquinolin-2-yl)formamido]butanoic acid

(2s)-4-(c-hydroxycarbonimidoyl)-2-[(3-hydroxyquinolin-2-yl)formamido]butanoic acid

C15H15N3O5 (317.1012)